Treatment Approved for Multiple Sclerosis

Also known as MS, multiple sclerosis is a chronic disease that affects the central nervous system wherein the sheaths of myelin in the nerves are damaged, thus impairing the conduction of signals through affected nerves.

The sickness can cause a variety of symptoms, including changes in sensation, visual problems, muscle weakness, depression, difficulties with coordination and speech, severe fatigue, cognitive impairment, problems with balance, overheating, and pain.

It can also cause impaired mobility and disability. MS primarily affects adults, and is more common in women than in men.

There is no known cure for multiple sclerosis, but several types of therapy have proven to be helpful. Treatment is aimed at returning function after an attack, preventing new attacks, and preventing disability.

Intravenous corticosteroids – High doses of intravenous corticosteroids such as methylprednisolone are given to patients who are suffering from "attacks" linked to MS.

Interferons – These are medications derived from human cytokines, which help regulate the immune system. It aims to prevent MS attacks.

Glatiramer acetate – This is a synthetic medication made of four amino acids that are found in the myelin. This drug stimulates cells in the body’s immune system to change from harmful, pro-inflammatory agents to beneficial, anti-inflammatory agents that work to reduce inflammation at lesion sites.

Mitoxantrone – Although this medication is effective in preventing attacks, it is prone to cardiotoxicity.

Natalizumab – This medication is effective and safe to be taken alone, but in combination with other related medicine can lead to progressive multifocal leukoencephalopathy, a rare and usually fatal viral disease.